Related Experiment Video

Updated: Jul 16, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K

Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo

N Gassler1, C Zhang2, T Wenger2

  • 1Department of Pathology, University of Heidelberg, Heidelberg, Germany.

British Journal of Cancer
|September 18, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.1K

Related Experiment Videos

Last Updated: Jul 16, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.1K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

Articles linked to this work by shared authors, journal, and citation graph.

Ruthenium-catalyzed oxidative cleavage of olefins to aldehydes.

The Journal of organic chemistry·2001

The leukocyte common antigen-related protein tyrosine phosphatase receptor regulates regenerative neurite outgrowth in vivo.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2001

Pharmacokinetics of testosterone after percutaneous gel or buccal administration.

Fertility and sterility·2001

Calpain activity in the rat brain after transient forebrain ischemia.

Experimental neurology·2001

Sharpening low-energy, standard-model tests via correlation coefficients in neutron beta decay.

Physical review letters·2001

Creation of chimeric mutant axolotls: a model to study early embryonic heart development in Mexican axolotls.

Anatomy and embryology·2001

CXCL14+ fibroblasts promote development of IBD-associated fibrosis and cancer by interacting with SPP1+ macrophages via collagen IV secretion.

British journal of cancer·2026

Waiting times and determinants of delay for head and neck cancer in England-a population cohort study using real world data.

British journal of cancer·2026

Preclinical efficacy of a systemically-administered, second-generation STING agonist that promotes anti-tumour immunity in combination with radiotherapy.

British journal of cancer·2026

Paediatric therapeutic development workshop on desmoplastic small round cell tumours.

British journal of cancer·2026

Using the Geriatric Core Dataset (G-CODE) to predict mortality in older patients with cancer: development and external validation.

British journal of cancer·2026

Hypoxia-induced HMGB1/NLRP3/Caspase-1 signaling axis enhances proliferation of oral squamous cell carcinoma.

British journal of cancer·2026

When the Tumor Disappears, Must the Larynx Follow?

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Oncolytic Vaccinia Virus Armed With CLEC2A Enhances Antitumor Immunity via ROS-Autophagy Feedback Loop and Cytokine Activation.

Journal of medical virology·2026

Streptozotocin-based chemotherapy in advanced PanNETs: a systematic review and meta-analysis.

Endocrine-related cancer·2026

First-line osimertinib with or without chemotherapy for EGFR-mutant advanced NSCLC in China: a cost-effectiveness analysis.

Future oncology (London, England)·2026

Clinical predictors of treatment success following Gasserian ganglion conventional radiofrequency in trigeminal neuralgia: secondary cohort analysis.

Journal of oral & facial pain and headache·2026

[Scar tissue in the skin].

Ugeskrift for laeger·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us